Free tool
Stocks listed on Nasdaq GS
We cover 16 companies listed on Nasdaq GS. The median market value in the group is $7.98B. Across the group, the median move over the past trading day is −0.74%. Price change over the past year runs from +43.5% to +287.2% across the middle 80 percent of the group, with a median of +84.9%.
Other lists in this group
Table
16 of 1,279 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% |
| ILMN | Illumina, Inc. | $33.95B | Large cap | +125.88% |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +46.30% |
| RGEN | Repligen Corporation | $10.25B | Large cap | +51.67% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +179.08% |
| TXG | 10x Genomics, Inc. | $8.37B | Mid cap | +358.35% |
| CAI | Caris Life Sciences, Inc. | $7.58B | Mid cap | −29.83% |
| HTFL | Heartflow, Inc. | $4.26B | Mid cap | +40.79% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.13B | Mid cap | +292.38% |
| IDYA | IDEAYA Biosciences, Inc. | $4.01B | Mid cap | +66.32% |
| ABCL | AbCellera Biologics Inc. | $3.97B | Mid cap | +181.38% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $3.30B | Mid cap | +281.97% |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +73.50% |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +96.28% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.